Delfi Diagnostics Raises $225M in Series B Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Delfi Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection...
The firm will use the funds to help support the development of cell-free DNA based cancer early detection and monitoring tests.
/PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, will...
The Baltimore biotech ecosystem is thriving, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.